Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

Bezafibrate, Beza, BZF, Bezalip

[1] Bezafibrate (Bezalip SR)

[1] Bezafibrate 💬

[1] PPARA 💬

[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬

[1] 93 💬

2

Bezafibrate, Beza, BZF, Bezalip mono

[1] Bezafibrate (Bezalip SR)

[1] Bezafibrate 💬

[1] PPARA 💬

[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬

[1] 93 💬

3

-

-

-

-

[3] 93, 94, 160 💬

4

-

-

-

-

[1] 93 💬

5

-

-

-

-

[1] 160 💬